Even as FDA has made strides over the past two years to shorten drug approval timelines, the agency takes longer to approve drugs for diseases like cardiovascular disease, obesity, and diabetes than for several forms of cancer, hepatitis C, lupus, pneumonia, and orphan diseases, a report issued this morning concluded.